Jones M. J., Goodman S. J., Kobor M. S.. DNA Methylation and Healthy Human Aging. „Aging Cell”. 14, s. 924–932, 2015. DOI: 10.1111/acel.12349.
Deaton A. M., Bird A.. CpG Islands and the Regulation of Transcription. „Genes & Development”. 25, s. 1010–1022, 2011. DOI: 10.1101/gad.2037511.
Piletič K., Kunej T.. MicroRNA Epigenetic Signatures in Human Disease. „Archives of Toxicology”. 90 (10), s. 2405–2419, 2016. DOI: 10.1007/s00204-016-1815-7.
Illingworth R. S., Bird A. P.. CpG Islands – ‘A Rough Guide’. „FEBS Letters”. 583, s. 1713–1720, 2009. DOI: 10.1016/j.febslet.2009.04.012.
Panchin, Makeev V. J., Medvedeva Y. A.. Preservation of Methylated CpG Dinucleotides in Human CpG Islands. „Biology Direct”. 11, s. 11, 2016. DOI: 10.1186/s13062-016-0113-x.
Lujambio A., Esteller M.: CpG Island Hypermethylation, miRNAs, and Human Cancer. W: Ying Sh. Y.: Current Perspectives im microRNAs (miRNA). Springer, 2008, s. 368. DOI: 10.1007/978-1-4020-8533-8. ISBN 978-1-4020-8532-1.
Campan M., Weisenberger D. J., Laird P. W.: DNA Methylation Profiles of Female Steroid Hormone-Driven Human Malignancies. W: Doerfler W., Böhm P.: DNA Methylation: Development, Genetic Disease and Cancer. Springer, 2006, s. 147. DOI: 10.1007/3-540-31181-5. ISBN 978-3-540-31180-5.
Goela N., Karira P., Gargb V. K.. Role of DNA Methylation in Human Age Prediction. „Mechanisms of Ageing and Development”. 166, s. 33–41, 2017. DOI: 10.1016/j.mad.2017.08.012.